Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-11-07A Multicenter, Randomized, Double-blind Study of Dacarbazine With or Without Genasense in Chemotherapy-naive Subjects With Advanced Melanoma and Low LDH (The AGENDA Trial)
-
CLINICAL_TRIALS study record update · 2011-11-02Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
-
CLINICAL_TRIALS study record update · 2011-10-13A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL281 Administered Orally to Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2011-09-28A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-09-16Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines: A Phase I Trial to Assess Safety and Immune Response
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-08-19Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases. A Phase II, Prospective, Open, Multicenter Trial
-
CLINICAL_TRIALS study record update · 2011-07-07A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-06-23A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma
-
CLINICAL_TRIALS study record update · 2011-06-10Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
-
CLINICAL_TRIALS study record update · 2011-06-08A Phase II Multicenter Study to Test Progression-free and Overall Survival of CY-503 in the Treatment of Patients With Unresectable Stage IV Metastatic Melanoma After Antineoplastic Treatment Failure
-
CLINICAL_TRIALS study record update · 2011-06-01Phase II Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Dacarbazine (DTIC) Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2011-05-12A Phase II, Open Label, Single Arm, "Proof of Concept" Study of TNFerade™ Plus Radiation in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-04-20Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy - A Phase I Trial in Melanoma
-
CLINICAL_TRIALS study record update · 2011-04-20Differential Risks for Melanoma: p16 and DNA Repair
-
CLINICAL_TRIALS study record update · 2011-03-28Injection of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response
-
CLINICAL_TRIALS study record update · 2011-03-24Efficacy and Safety of High-dose Treatment With the Immunomodulator Interferon-α-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma.
-
CLINICAL_TRIALS study record update · 2011-03-10Partner Assistance in Learning and Performing Skin Self-Examination
-
CLINICAL_TRIALS study record update · 2011-02-23A Phase I/II Study of Sunitinib and Dacarbazine in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-02-23Phase III Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Paclitaxel/Carboplatin Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-28A Randomized Study Comparing MDX-010 (CTLA-4) Alone or in Combination With DTIC in the Treatment of Patients With Chemotherapy Naїve Metastatic Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-25A Phase II, Multi-center, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of BAY 43-9006 Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-24Comparison of Diagnostic and Biopsy/Referral Sensitivity to Melanoma Between Three Groups of Physicians and MelaFind
-
CLINICAL_TRIALS study record update · 2011-01-13A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b (PEG-Intron)and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2011-01-12Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma: a Prospective Non-randomized, Multicenter Phase II Study
-
CLINICAL_TRIALS study record update · 2010-12-17Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma